{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T11:05:14Z","timestamp":1779879914447,"version":"3.53.1"},"reference-count":23,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T00:00:00Z","timestamp":1778803200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and Objectives: Elective electrical cardioversion (eECV) in patients with atrial fibrillation (AF) or atrial flutter is associated with a low risk of thromboembolic events (TEs) when adequate anticoagulation is provided. However, the role of routine transesophageal echocardiography (TEE) prior to eECV remains uncertain. This study aimed to assess thromboembolic outcomes in patients undergoing eECV with or without TEE guidance in a real-world clinical setting. Methods: A single-center, combined retrospective\u2013prospective observational study including 296 adequately anticoagulated patients with AF or atrial flutter scheduled for eECV was conducted. The retrospective cohort (n = 220) underwent eECV without routine TEE, while the prospective cohort (n = 85) underwent TEE prior to eECV. The primary outcome was the occurrence of thromboembolic events (ischemic stroke or systemic embolism) within 30 days after eECV. Arrhythmia recurrence at 30 days was assessed as a secondary, exploratory outcome. Results: Among patients undergoing eECV, thromboembolic events were rare. In the retrospective cohort, 3\/220 patients (1.36%) experienced a TE, whereas no events were observed in the prospective cohort (0\/76). Due to the low number of events, the study was underpowered to detect meaningful differences between strategies (RR 2.44; 95% CI 0.13\u201346.7; p = 0.55). TEE identified left atrial appendage thrombus in 9\/85 screened patients (10.6%), who were subsequently excluded from cardioversion. Arrhythmia recurrence at one month was more frequent in the prospective cohort (19.7% vs. 7.3%), likely reflecting differences in baseline clinical characteristics. Conclusions: Thromboembolic events after eECV in adequately anticoagulated patients were infrequent in this real-world cohort. While the study design limits direct comparison between strategies, the results indicate that a conventional anticoagulation-based approach without routine TEE is associated with a low risk of thromboembolic events in most patients. At the same time, the detection of left atrial appendage thrombus in a subset of patients underscores the importance of individualized risk assessment and supports the selective use of TEE in higher-risk clinical settings.<\/jats:p>","DOI":"10.3390\/medicina62050970","type":"journal-article","created":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T10:19:52Z","timestamp":1779877192000},"page":"970","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical Assessment of Thromboembolic Risk in Patients Undergoing Elective Electrical Cardioversion with or Without Transesophageal Echocardiography: A Real-World Observational Study"],"prefix":"10.3390","volume":"62","author":[{"given":"Ana","family":"Petreti\u0107","sequence":"first","affiliation":[{"name":"Clinic for Cardiovascular Diseases, University Hospital Center Rijeka, 51000 Rijeka, Croatia"},{"name":"Faculty of Medicine, University of Rijeka, 51000 Rijeka, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-4525-9103","authenticated-orcid":false,"given":"Fabio","family":"Kadum","sequence":"additional","affiliation":[{"name":"Clinic for Cardiovascular Diseases, University Hospital Center Rijeka, 51000 Rijeka, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulina","family":"Ku\u0161an","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Rijeka, 51000 Rijeka, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5931-2872","authenticated-orcid":false,"given":"Gordana","family":"\u017dauhar","sequence":"additional","affiliation":[{"name":"Department of Medical Physics and Biophysics, Faculty of Medicine, University of Rijeka, 51000 Rijeka, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2837-4157","authenticated-orcid":false,"given":"Lara","family":"Bati\u010di\u0107","sequence":"additional","affiliation":[{"name":"Department of Medical Chemistry, Biochemistry and Clinical Chemistry, Faculty of Medicine, University of Rijeka, 51000 Rijeka, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8722-9497","authenticated-orcid":false,"given":"Robert","family":"Bernat","sequence":"additional","affiliation":[{"name":"Clinic for Internal Medicine 2, Cardiology, Pulmonology, Angiology and Internal Intensive Care Medicine, Westpfalz-Klinikum Kaiserslautern, 67655 Kaiserslautern, Germany"},{"name":"Faculty of Medicine, University of Osijek, 31000 Osijek, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,5,15]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1093\/eurheartj\/ehae176","article-title":"2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): Developed by the task force for the management of atrial fibrillation of the European Society of Cardiology (ESC), with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Endorsed by the European Stroke Organisation (ESO)","volume":"45","author":"Rienstra","year":"2024","journal-title":"Eur. Heart J."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ccep.2020.10.010","article-title":"Epidemiology of atrial fibrillation: Geographic\/ecological risk factors, age, sex, genetics","volume":"13","author":"Zhang","year":"2021","journal-title":"Card. Electrophysiol. Clin."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.jval.2023.12.015","article-title":"The cost of atrial fibrillation: A systematic review","volume":"27","author":"Buja","year":"2024","journal-title":"Value Health"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"100784","DOI":"10.1016\/j.lanepe.2023.100784","article-title":"Atrial fibrillation: Comorbidities, lifestyle, and patient factors","volume":"37","author":"Shantsila","year":"2024","journal-title":"Lancet Reg. Health Eur."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"316","DOI":"10.5455\/medarh.2017.71.316-319","article-title":"The cumulative incidence of stroke, myocardial infarction, heart failure, and sudden cardiac death in patients with atrial fibrillation","volume":"71","author":"Naser","year":"2017","journal-title":"Med. Arch."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"A19","DOI":"10.1093\/eurheartj\/suab151","article-title":"Non-vitamin K antagonist oral anticoagulants in patients with valvular heart disease","volume":"24","author":"Fanaroff","year":"2022","journal-title":"Eur. Heart J. Suppl."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1093\/europace\/eut395","article-title":"The European Heart Rhythm Association symptom classification for atrial fibrillation: Validation and improvement through a simple modification","volume":"16","author":"Wynn","year":"2014","journal-title":"Europace"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"153","DOI":"10.5830\/CVJA-2019-064","article-title":"Treatment of atrial fibrillation: A comprehensive review and practice guide","volume":"31","author":"Li","year":"2020","journal-title":"Cardiovasc. J. Afr."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"e010854","DOI":"10.1161\/JAHA.118.010854","article-title":"Use of direct oral anticoagulants among patients undergoing cardioversion: The importance of timing before cardioversion","volume":"7","author":"Warden","year":"2018","journal-title":"J. Am. Heart Assoc."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/j.jacc.2013.04.089","article-title":"Thromboembolic complications after cardioversion of acute atrial fibrillation: The FinCV (Finnish Cardioversion) study","volume":"62","author":"Airaksinen","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1093\/europace\/euz257","article-title":"Diagnosis and management of left atrial appendage thrombus in patients with atrial fibrillation undergoing cardioversion or percutaneous left atrial procedures: Results of the European Heart Rhythm Association survey","volume":"22","author":"Farkowski","year":"2020","journal-title":"Europace"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.amjcard.2018.09.027","article-title":"Prevalence and resolution of left atrial thrombus in patients with nonvalvular atrial fibrillation and flutter with oral anticoagulation","volume":"123","author":"Niku","year":"2019","journal-title":"Am. J. Cardiol."},{"key":"ref_13","first-page":"373","article-title":"2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC","volume":"42","author":"Hindricks","year":"2023","journal-title":"Europace"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"3346","DOI":"10.1093\/eurheartj\/ehu367","article-title":"Rivaroxaban vs. vitamin K antagonists for cardioversion in atrial fibrillation","volume":"35","author":"Cappato","year":"2014","journal-title":"Eur. Heart J."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1016\/S0140-6736(16)31474-X","article-title":"Edoxaban versus enoxaparin\u2013warfarin in patients undergoing cardioversion of atrial fibrillation (ENSURE-AF): A randomised, open-label, phase 3b trial","volume":"388","author":"Goette","year":"2016","journal-title":"Lancet"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2959","DOI":"10.1093\/eurheartj\/ehy148","article-title":"Apixaban compared to heparin\/vitamin K antagonist in patients with atrial fibrillation scheduled for cardioversion: The EMANATE trial","volume":"39","author":"Ezekowitz","year":"2018","journal-title":"Eur. Heart J."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1016\/j.jacc.2009.07.040","article-title":"Transesophageal echocardiography before atrial fibrillation ablation: Looking before cooking","volume":"54","author":"Knight","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"ehaf784.809","DOI":"10.1093\/eurheartj\/ehaf784.809","article-title":"Is pre-procedural transesophageal echocardiography necessary in patients undergoing catheter ablation for atrial fibrillation under uninterrupted anticoagulation?","volume":"46","author":"Mohanty","year":"2025","journal-title":"Eur. Heart J."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1001\/jamacardio.2025.3687","article-title":"Intracardiac vs Transesophageal Echocardiography in Atrial Fibrillation Ablation: A Randomized Clinical Trial","volume":"10","author":"Hu","year":"2025","journal-title":"JAMA Cardiol."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Romero, J., Husain, S.A., Kelesidis, I., Sanz, J., Medina, H.M., Garcia, M.J., Kim, J.H., Kwon, D.H., Reddy, V.Y., and Garcia, F.C. (2023). Detection of left atrial appendage thrombus by cardiac imaging in patients with atrial fibrillation: A meta-analysis. JACC Cardiovasc. Imaging, 6.","DOI":"10.1161\/CIRCIMAGING.112.000153"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1056\/NEJMoa2212540","article-title":"Progression of Atrial Fibrillation after Cryoablation or Drug Therapy","volume":"388","author":"Andrade","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"ref_22","first-page":"88","article-title":"Real-World Evaluation of Anticoagulant Treatment Patterns in Patients with Atrial Fibrillation: Data from Multicenter ROTA Study","volume":"51","author":"Ergin","year":"2023","journal-title":"Turk Kardiyol. Dern. Ars."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"64","DOI":"10.15441\/ceem.17.286","article-title":"Effectiveness and safety of electrical cardioversion for acute-onset atrial fibrillation in the emergency department: A real-world 10-year single center experience","volume":"6","author":"Bonfanti","year":"2019","journal-title":"Clin. Exp. Emerg. Med."}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/62\/5\/970\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T10:29:20Z","timestamp":1779877760000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/62\/5\/970"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,15]]},"references-count":23,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,5]]}},"alternative-id":["medicina62050970"],"URL":"https:\/\/doi.org\/10.3390\/medicina62050970","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,15]]}}}